Abstract
The objective was to assess the frequencies of haemochromatosis (HFE) gene mutations or variants C282Y, H63D and S65C in ethnic Danes. This is a prospective epidemiologic population study. A cohort of 6,020 Danish men aged 30–50 years was screened for HFE C282Y (c845G→A), H63D (c187C→G) and S65C (c193A→T) gene variants, assessed on saliva or blood samples by restriction fragment length polymorphism (RFLP) analysis. The C282Y gene variant allele was present in 5.6%, H63D in 12.8% and S65C in 1.8% of the chromosomes. In the entire series, we observed 1.4% H63D/C282Y, 0.1% S65C/C282Y and 0.4% H63D/S65C compound heterozygotes. The C282Y allele frequency in Denmark is of similar order as reported in other Scandinavian countries: Iceland 5.1%, Faeroe Islands 6.6%, Norway 6.8% and Sweden 5.8%. Also, the H63D frequency in Denmark is close to the frequencies in other Scandinavian countries: Iceland 10.9%, Faeroe Islands 15.2%, Norway 11.4% and Sweden 12.1%.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hereditary HFE-associated haemochromatosis is a disorder of iron metabolism, which in many individuals causes an inappropriately high intestinal absorption of dietary iron and induces progressive body iron overload [1]. The excess iron is deposited in parenchymal organs including the liver, heart and pancreas and may lead to liver cirrhosis, hepatocellular carcinoma, diabetes mellitus and cardiomyopathy [2].
The discovery of the HFE gene mutations or variants in 1996 [3] had great impact on clarification of the pathophysiology and diagnostic approach of haemochromatosis. More than 90% of patients of northern European ancestry with clinical haemochromatosis are homozygous for the C282Y variant, which is a G→A transition at nucleotide 845 in the open reading frame [4, 5].
Based on phenotypic screening (serum transferrin saturation, serum ferritin) the prevalence of haemochromatosis in Denmark has been estimated to 0.37–0.46% [6], i.e. between 1 in 217 and 1 in 270 persons of ethnic Danish origin.
Previous studies of ethnic Danes have reported a C282Y variant frequency of 5.7% [7], which is close to the estimated allele frequency of ~6.1% derived from phenotypic screening [6]. Consequently, the phenotypic/genotypic haemochromatosis allele ratio in Denmark is close to 1 [8].
HFE haemochromatosis is inherited as an autosomal recessive trait [9]. Since the identification of the HFE gene and its variants, hereditary haemochromatosis is emerging as one of the most common genetic disorders among populations of northern European descent [10]. The purpose of the present study was twofold. Firstly, to describe the frequency of the three most common HFE variants C282Y (c845G→A), H63D (c187C→G) and S65C (c193A→T) in a population of ethnic Danish men. Secondly, to assess the penetrance of the variants on the occurrence of biochemical and clinical haemochromatosis. In this paper we describe the frequencies of the HFE variants, additional results will be published separately.
Materials and methods
Participants
This prospective, epidemiologic population study was performed in 2000–2001. It was approved by The Danish Scientific Ethical Committee and fulfilled The Declaration of Helsinki. All men of ethnic Danish origin aged 30–50 years (n = 10,993) being residents in the municipalities of Næstved and Vordingborg in the southern part of Zealand were invited by letter to participate. Written informed consent was obtained from all participants.
HFE variant analyses
Saliva samples for analysis of HFE genotype were taken by the participants and sent by mail to our laboratory. Samples were obtained from 6,567/10,993 (60%) participants. In 1,064 subjects, the genotype could not be determined on saliva. They were invited to have a blood sample drawn for genetic testing, which was obtained in 517 subjects. Thus the HFE genotype was assessed in 6,020/10,993 (55%) of the population initially being invited.
Extraction of DNA from saliva and blood was performed using the method of Rudbeck and Dissing [11] with minor modifications. The stop-mixture contained cresol-red in order to ensure a visual verification, when the DNA sample was transferred to the polymerase chain reaction (PCR) tube. Cresol-red did not interfere with the PCR [12]. For each PCR, 4 µl DNA extract was used as template in a 50 µl reaction mixture in the presence of 0.5 µM of each primer, 40 µM of each dNTP, 75 mM Tris (pH 8.8), 20 mM (NH4)2SO4, 0.01% tween 20, 1.5 mM MgCl2, and 0.02 U Taq polymerase (Fermentas UAB, Lithuania). Two primer sets were used: C282Ys (5′-CCCCCAGAACATCACCATGAA)/C282Yas (5′-CCCCTAACAAAGAGCAGATCC) and H63D/S65Cs (5′-GTTGCTCTGTCTCCAGGATCACACTCTC)/H63D/S65Cas (5′-TCCCACCCTTTCAGACTCTGTCTCAG). The HFE H63D/S65C primers included internal control restriction enzyme sites for each of the enzymes used for this assay (underscore). Cycling parameters for the HFE H63D/S65C PCR were 94°C initial denaturation for 5 min, 94°C DNA denaturation for 60 s, 54°C primer annealing for 60 s, 72°C primer extension for 60 s, carried out for 35 cycles, and finally a prolonged DNA extension at 72°C for 5 min to complete the reaction. Cycling parameters for the HFE 845 PCR were 94°C initial denaturation for 5 min, 94°C for 40 s, 55°C for 60 s, 72°C for 60 s, carried out for 5 cycles, 94°C for 40 s, 56°C for 40 s, 72°C for 40 s, carried out for 30 cycles, and finally a prolonged DNA extension at 72°C for 5 min to complete the reaction. The amplified PCR fragments were digested with restriction endonucleases RsaI (C282Y) and Bsp143I and HinfI identified the H63D and S65C variants, respectively. Digest was performed according to the manufacturer’s (Fermentas UAB, Lithuania) recommendation. The digested products were electrophoresed and visualised after ethidium bromide staining.
Three cases of HFE 845A and 187G in “cis” phase have been reported [13–15]. Such a genotype was not found in our study. We consider it a rare exception and assume that all chromosomes contain only one of the three variants. The most common HFE genotypes C282, H63, and S65 are designated wild type (wt) in this paper.
Statistics
Hardy–Weinberg equilibrium in the observed genotype distribution was assessed with χ2-goodness-of-fit test. The significance level was set at 0.05. Differences in HFE variant frequencies were tested with χ2-test.
Results
The HFE genotype distribution in this population was consistent with the Hardy-Weinberg equilibrium (χ2 = 5.4, p = 0.8).
Table 1 shows the number and composition of the HFE genotypes. The allele frequency of the C282Y, H63D and S65C variants was 5.6%, 12.8% and 1.8%, respectively. In the entire series, we observed 1.4% H63D/C282Y, 0.1% S65C/C282Y and 0.4% H63D/S65C compound heterozygotes.
Discussion
Following the discovery of the HFE gene mutations in 1996 [3], many genetic population surveys have been reported [16]. The frequency of the C282Y variant is highest among people in Northern Europe, comprising Ireland, UK and Scandinavia [16]. The frequency displays a decreasing gradient from Northern to Southern Europe and from Western to Eastern Europe [16]. The prevalence of homozygosity for the C282Y variant in a series of ethnic Danish patients with clinical genetic haemochromatosis was 96% [17], stressing the importance of this variant in hereditary iron overloading disorders in subjects of Danish heritage. In Danes, there is good agreement between the genetic frequency of C282Y homozygosity of 0.36% in the present study and the phenotypic (using serum transferrin saturation and serum ferritin) frequency of ~0.37% in male blood donors [6].
Genetic studies of the HFE variants in Danes [18–21] are shown in Table 2. The study of Merryweather-Clarke et al. [18], which was performed on Guthrie cards from Danish newborns, differ from the other Danish studies [7, 19–22]. In the total series of Danes (n = 19,170) the frequency of the C282Y variant was 5.6%. The results of the present study were not significantly different from other Danish studies [7, 19–22].
The allele frequencies of C282Y in the other Nordic countries [18, 23–27] are shown in Table 3 and the cumulated frequencies in Table 4. The frequency of the C282Y variant in the total series of Danes (n = 19,170) was not significantly different from the frequency in Iceland and Sweden, but significantly lower than the frequency in the Faeroe Islands (p < 0.05) and Norway (p < 0.01). The C282Y frequency was significantly higher in Danes than in Finns (p < 0.001) [26], who have the lowest frequency among the Nordic countries. However, the Finnish people are not of Nordic origin, but related to the Hungarian people, who originally came from the Ural region.
In the total series of Danes (n = 19,170) the frequency of the H63D variant was 12.8%. The present result, derived from a male population (n = 6,020) was similar to previous Danish studies (Table 2). The allele frequency of the H63D variant in Danes was not significantly different from that reported in Iceland, Norway and Sweden, but significantly lower than the frequency in the Faeroe Islands (p < 0.01).
The S65C frequency in the total series of Danes (n = 7,039) was not significantly different from that reported in Sweden and Finland, but significantly lower than the frequency in the Faeroe Islands (p < 0.05).
The frequency of C282Y/H63D compound heterozygotes (1.44%) was similar to the frequency of 1.42% found in the previous study from Copenhagen [21] and not significantly different from the frequency of 1.72% in a series of Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods [14].
We have hypothesised that the C282Y mutation originated among the population in Southern Scandinavia or Northern Germany and was spread to other parts of Northern Europe by the Vikings in the period 700–1050 [16]. Around the turn of the first millennium, Scandinavian Vikings became marine emigrants, who conquered coastal country and established settlements nearby the sea. The highest frequencies of the C282Y variant are found in the coastal areas of Northern Europe. The Viking influence was dominant in Denmark, Iceland, the Faeroe Islands, Norway, Sweden as well as the Aaland Islands and prominent in Scotland, England, Ireland and Northern France.
In hereditary HFE C282Y haemochromatosis, women present with clinical symptoms at a higher age than men [28], probably because they are partly protected against iron overload due physiological iron losses with menstruation and pregnancy [29]. Men have significantly smaller physiological iron losses than women and a higher intake of dietary iron, alcohol and red meat [11, 12, 30–33]. Lifestyle factors, e.g. alcohol intake and red meat consumption tend to increase serum ferritin levels and body iron stores and consequently have an enhancing effect on the phenotypic frequency by increasing the biochemical penetrance i.e. elevated serum transferrin saturation and serum ferritin as well as the clinical penetrance, i.e. organ damage.
Hereditary haemochromatosis is the most prevalent hereditary disorder in people of northern European heritage. However, the biochemical and clinical penetrance of the C282Y variant in its homozygous form appears to be incomplete and display considerable variation between different populations [30–34]. This in part explains the discrepancy between the high frequency of C282Y homozygosity and the low incidence of clinical haemochromatosis. In Denmark, the expected frequency of C282Y homozygosity is 0.31%. The ethnic population in Denmark is ~5,000,000 persons, i.e. there are ~16,000 C282Y homozygous individuals. Yet in the period 1950–1985, less than 200 patients with clinical haemochromatosis were diagnosed in Denmark [2]. The situation is similar in the Faeroe Islands. The C282Y variant frequency is 8.0% and the frequency of homozygosity 0.64%. The Faeroese population consists of ~40,000 persons, i.e. there should be ~260 C282Y homozygous individuals. However, only a few families with hereditary haemochromatosis have been identified [35]. Apparently, the incomplete penetrance of C282Y homozygosity decreases the clinical impact of this variant.
In conclusion, in the Danish population, the HFE gene variants C282Y, H63D and S65C are quite common and the genetic predisposition for haemochromatosis is therefore relatively high. In daily clinical practice, the diagnostic awareness should be focused on subjects at risk for genetic iron overload by widespread assessment of biochemical iron status. Furthermore, relatives to probands with hereditary haemochromatosis should be tested by genetic methods for HFE variants and if found positive also tested by biochemical methods in order to clarify their lifetime risk of iron overload disease.
References
Barton JC (2000) A brief history of hemochromatosis. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 3–7
Milman N (1991) Hereditary haemochromatosis in Denmark 1950–1985. Clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Med Bull 38:385–393 Medline
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399–408 Medline. DOI 10.1038/ng0896-399
Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW et al (1996) Haemochromatosis and HLA-H. Nat Genet 14:249–251 Medline. DOI 10.1038/ng1196-249
Koefoed P, Dalhoff K, Dissing J, Kramer I, Milman N, Pedersen P et al (2002) HFE mutations and hemochromatosis in Danish patients admitted for HFE genotyping. Scand J Clin Lab Invest 62:527–535 Medline. DOI 10.1080/003655102321004549
Wiggers P, Dalhøj J, Kiær H, Ring-Larsen H, Petersen PH, Blaabjerg O et al (1991) Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 230:265–270 Medline
Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol 83:654–657 Medline. DOI 10.1007/s00277-004-0874-7
Milman N, Pedersen P, Steig T, Melsen GV (2003) Frequencies of the hereditary hemochromatosis allele in different populations. Comparison of previous phenotypic methods and novel genotypic methods. Int J Hematol 77:48–54 Medline
Milman N (2000) Inheritance of hemochromatosis: family studies. In: Barton JC, Edwards CQ (eds) Hemochromatosis: genetics, pathophysiology, diagnosis and treatment. Cambridge University Press, Cambridge, UK, pp 15–41
Worwood M (1998) Haemochromatosis. Clin Lab Haematol 20:65–75 Medline. DOI 10.1046/j.1365-2257.1998.00028.x
Rudbeck L, Dissing J (1998) Rapid, simple alkaline extraction of human genomic DNA from whole blood, buccal epithelial cells, semen and forensic stains for PCR. Biotechniques 25:588–590 Medline
Hoppe BL, Conti-Tronconi BM, Horton RM (1992) Gel-loading dyes compatible with PCR. Biotechniques 12:679–680 Medline
Thorstensen K, Asberg A, Kvitland M, Svaasand E, Hveem K, Bjerve KS (2000) Detection of an unusual combination of mutations in the HFE gene for hemochromatosis. Genet Test 4:371–376 Medline. DOI 10.1089/109065700750065117
Lucotte G, Champenois T, Semonin O (2001) A rare case of a patient heterozygous for the hemochromatosis mutation C282Y and homozygous for H63D. Blood Cells Mol Dis 27:892–893 Medline. DOI 10.1006/bcmd.2001.0451
Best LG, Harris PE, Spriggs EL (2001) Hemochromatosis mutations C282Y and H63D in ‘cis’ phase. Clin Genet 60:68–72 Medline. DOI 10.1034/j.1399-0004.2001.600111.x
Milman N, Pedersen P (2003) Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 64:36–47 Medline. DOI 10.1034/j.1399-0004.2003.00083.x
Milman N, Koefoed P, Pedersen P, Nielsen FC, Eiberg H (2003) Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods. Eur J Haematol 71:403–407 Medline. DOI 10.1046/j.0902-4441.2003.00156.x
Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13:154–159 Medline. DOI 10.1002/(SICI)1098-1004(1999)13:2<154::AID-HUMU8>3.0.CO;2-E
Steffensen R, Varming K, Jersild C (1998) Determination of gene frequencies for two common haemochromatosis mutations in the Danish population by a novel polymerase chain reaction with sequence-specific primers. Tissue Antigens 52:230–235 Medline
Simonsen K, Dissing J, Rudbeck L, Schwartz M (1999) Rapid and simple determination of hereditary haemochromatosis mutations by multiplex PCR-SSCP: detection of a new polymorphic mutation. Ann Hum Genet 63:193–197 Medline. DOI 10.1046/j.1469-1809.1999.6330193.x
Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M et al (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 358:1405–1409 Medline. DOI 10.1016/S0140-6736(01)06526-6
Bathum L, Christiansen L, Nybo H, Ranberg KA, Gaist D, Jeune B et al (2001) Association of mutations in the hemochromatosis gene with shorter life expectancy. Arch Intern Med 161:2441–2444 Medline. DOI 10.1001/archinte.161.20.2441
Distante S, Berg JP, Lande K, Haug E, Bell H (2000) HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis. Gut 47:575–579 Medline. DOI 10.1136/gut.47.4.575
Undlien DE, Bell H, Heier HE, Akselsen HE, Thorsby E (1998) Genetic diagnostic test for hemochromatosis. Tidsskr Nor Laegeforen 118:238–240 Medline
Beckman LE, Sjoberg K, Eriksson S, Beckman L (2001) Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered 52:110–112 Medline. DOI 10.1159/000053362
Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 100:1274–1279 Medline
Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278 Medline
Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K (2001) Clinically overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients. Ann Hematol 80:737–744 Medline. DOI 10.1007/s002770100371
Milman N, Clausen J, Byg KE (1998) Iron status in 268 Danish women aged 18–30 years: influence of menstruation, contraceptive method, and iron supplementation. Ann Hematol 77:13–19 Medline. DOI 10.1007/s002770050405
Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218 Medline. DOI 10.1016/S0140-6736(02)07447-0
Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW (1999) A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 341:718–724 Medline. DOI 10.1056/NEJM199909023411002
McDonnell SM, Hover A, Gloe D, Ou CY, Cogswell ME, Grummer-Strawn L (1999) Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. Am J Med 107:30–37 Medline. DOI 10.1016/S0002-9343(99)00163-1
Phatak PD, Ryan DH, Cappuccio J, Oakes D, Braggins C, Provenzano K et al (2002) Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients. Blood Cells Mol Dis 29:41–47 Medline. DOI 10.1006/bcmd.2002.0536
Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM et al (1998) The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830–836 Medline
Milman N, Graudal N, Nielsen LS, Mathiassen B, Tauris P, Lund B et al (1990) Family studies of hereditary hemochromatosis in Denmark and the Faroe Islands. Hum Genet 85:228–232 Medline. DOI 10.1007/BF00193201
Milman N, Steig T, Koefoed P, Pedersen P, Nielsen FC (2005) Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faeroe Islands. Ann Hematol 84:146–149 Medline. DOI 10.1007/s00277-004-0865-8
Distante S, Berg JP, Lande K, Haug E, Bell H (1999) High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression. Scand J Gastroenterol 34:529–534 Medline. DOI 10.1080/003655299750026290
Holmstrom P, Marmur J, Eggertsen G, Gafvels M, Stal P (2002) Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut 51:723–730 Medline. DOI 10.1136/gut.51.5.723
Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M et al (1998) HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 243:203–208 Medline. DOI 10.1046/j.1365-2796.1998.00270.x
Hannuksela J, Leppilampi M, Peuhkurinen K, Karkkainen S, Saastamoinen E, Helio T et al (2005) Hereditary hemochromatosis gene (HFE) mutations C282Y, H63D and S65C in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 7:103–108 Medline. DOI 10.1016/j.ejheart.2004.03.007
Halme L, Helio T, Makinen J, Hockerstedt K, Farkkila M, Piippo K et al (2001) HFE haemochromatosis gene mutations in liver transplant patients. Scand J Gastroenterol 36:881–885 Medline
Syrjakoski K, Fredriksson H, Ikonen T, Kuukasjarvi T, Autio V, Matikainen MP et al (2006) Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients. Int J Cancer 118:518–520 Medline. DOI 10.1002/ijc.21331
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pedersen, P., Melsen, G.V. & Milman, N. Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men. Ann Hematol 87, 735–740 (2008). https://doi.org/10.1007/s00277-008-0506-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0506-8